A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families
Memorial Sloan Kettering Cancer Center
10 participants
Nov 14, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
Eligibility
Inclusion Criteria6
- Adult (aged >18 years) MSK patients as per the EHR
- Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
- Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
- Must be English-speaking in the EHR
- Must be reachable by phone as per self-report
- Must have Wi-Fi available at home as per self-report
Exclusion Criteria1
- Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06693700